Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Danishefsky S. J., McClure K. F., Randolph J. T., Ruggeri R. B. A strategy for the solid-phase synthesis of oligosaccharides. Science. 1993 May 28;260(5112):1307–1309. doi: 10.1126/science.8493573. [DOI] [PubMed] [Google Scholar]
- Dedon P. C., Salzberg A. A., Xu J. Exclusive production of bistranded DNA damage by calicheamicin. Biochemistry. 1993 Apr 13;32(14):3617–3622. doi: 10.1021/bi00065a013. [DOI] [PubMed] [Google Scholar]
- Drak J., Iwasawa N., Danishefsky S., Crothers D. M. The carbohydrate domain of calicheamicin gamma I1 determines its sequence specificity for DNA cleavage. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7464–7468. doi: 10.1073/pnas.88.17.7464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Durand D. B., Bush M. R., Morgan J. G., Weiss A., Crabtree G. R. A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J Exp Med. 1987 Feb 1;165(2):395–407. doi: 10.1084/jem.165.2.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawley R. C., Kiessling L. L., Schreiber S. L. Model of the interactions of calichemicin gamma 1 with a DNA fragment from pBR322. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1105–1109. doi: 10.1073/pnas.86.4.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ho S. N., Boyer S. H., Schreiber S. L., Danishefsky S. J., Crabtree G. R. Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9203–9207. doi: 10.1073/pnas.91.20.9203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicolaou K. C., Smith A. L., Yue E. W. Chemistry and biology of natural and designed enediynes. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5881–5888. doi: 10.1073/pnas.90.13.5881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shaw J. P., Utz P. J., Durand D. B., Toole J. J., Emmel E. A., Crabtree G. R. Identification of a putative regulator of early T cell activation genes. Science. 1988 Jul 8;241(4862):202–205. doi: 10.1126/science.3260404. [DOI] [PubMed] [Google Scholar]
- Sugiura Y., Uesawa Y., Takahashi Y., Kuwahara J., Golik J., Doyle T. W. Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7672–7676. doi: 10.1073/pnas.86.20.7672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Uesugi M., Sugiura Y. New insights into sequence recognition process of esperamicin A1 and calicheamicin gamma 1I.: origin of their selectivities and "induced fit" mechanism. Biochemistry. 1993 May 4;32(17):4622–4627. doi: 10.1021/bi00068a020. [DOI] [PubMed] [Google Scholar]
- Walker S., Landovitz R., Ding W. D., Ellestad G. A., Kahne D. Cleavage behavior of calicheamicin gamma 1 and calicheamicin T. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4608–4612. doi: 10.1073/pnas.89.10.4608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zein N., Poncin M., Nilakantan R., Ellestad G. A. Calicheamicin gamma 1I and DNA: molecular recognition process responsible for site-specificity. Science. 1989 May 12;244(4905):697–699. doi: 10.1126/science.2717946. [DOI] [PubMed] [Google Scholar]
- Zein N., Sinha A. M., McGahren W. J., Ellestad G. A. Calicheamicin gamma 1I: an antitumor antibiotic that cleaves double-stranded DNA site specifically. Science. 1988 May 27;240(4856):1198–1201. doi: 10.1126/science.3240341. [DOI] [PubMed] [Google Scholar]